Richard Kelt
Metairie, LANPI 1376987131
Payments from drug & device makers
$1,973in general payments, 2019–2025
Across 111 payments — averaging $17.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tris Pharma Inc$328
- Supernus Pharmaceuticals, Inc.$311
- GSK$274
- Ironshore Pharmaceuticals Inc.$173
- Sanofi Pasteur Inc.$160
- Takeda Pharmaceuticals U.S.A., Inc.$118
- plus $609 from 12 others
What the payments were for
- Food & beverage$1,973100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tris Pharma Inc | 23 | $328 |
| Supernus Pharmaceuticals, Inc. | 12 | $311 |
| GSK | 17 | $274 |
| Ironshore Pharmaceuticals Inc. | 8 | $173 |
| Sanofi Pasteur Inc. | 9 | $160 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $118 |
| Seqirus USA Inc | 6 | $118 |
| Pfizer | 6 | $110 |
| Corium, LLC | 4 | $73 |
| Merck | 4 | $70 |
| Collegium Pharmaceutical, Inc. | 3 | $68 |
| Adlon Therapeutics L.p. | 4 | $57 |
| Neos Therapeutics, LP | 2 | $32 |
| Ironwood Pharmaceuticals, Inc | 1 | $22 |
| Sobi, Inc | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Hologic Sales And Service, LLC | 1 | $13 |
| Genentech USA, Inc. | 1 | $11 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.